These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2582424)

  • 1. Molecular characterization of MT3 antigens by two-dimensional gel electrophoresis, NH2-terminal amino acid sequence analysis, and southern blot analysis.
    Sorrentino R; Lillie J; Strominger JL
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3794-8. PubMed ID: 2582424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and functional evidence that an MT3 supertypic determinant defined by a monoclonal antibody is carried on the DR molecule on HLA-DR7 cell lines.
    Horibe K; Flomenberg N; Pollack MS; Adams TE; Dupont B; Knowles RW
    J Immunol; 1984 Dec; 133(6):3195-202. PubMed ID: 6208273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity.
    Matsuyama T; Schwenzer J; Silver J; Winchester R
    J Immunol; 1986 Aug; 137(3):934-40. PubMed ID: 2424991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
    Maeda H; Hirata R
    J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
    Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
    J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.
    Yabe T; Suzuki M; Satake M; Juji T; Hamaguchi H
    Immunogenetics; 1984; 20(2):155-67. PubMed ID: 6205988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular localization of human class II MT2 and MT3 determinants.
    Hurley CK; Giles RC; Nunez G; DeMars R; Nadler L; Winchester R; Stastny P; Capra JD
    J Exp Med; 1984 Aug; 160(2):472-93. PubMed ID: 6206179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DS molecules and their relation to supertypic specificities.
    Goyert SM; Moriuchi J; Winchester R; Silver J
    Hum Immunol; 1983 Sep; 8(1):53-63. PubMed ID: 6195135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new supertypic HLA class II determinant (PL2) differentially expressed with DR7, DRw11(5), DRw13(w6), DRw14(w6), DR3, and DR2 and biochemically localized to DR7 molecules.
    Horibe K; Knowles RW; Dupont B
    Hum Immunol; 1986 May; 16(1):14-23. PubMed ID: 2423484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility.
    Goyert SM; Silver J
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5719-23. PubMed ID: 6193521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the MT3 molecule using two-dimensional gel electrophoresis and alloantisera.
    Suzuki M; Maeda H; Mukai R; Yabe T; Hamaguchi H
    Immunogenetics; 1983; 18(6):575-83. PubMed ID: 6197369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-dimensional gel analysis of a second family of class II molecules by polymorphic HLA-DR4,5, and w9 monoclonal antibodies.
    Maeda H; Hirata R; Okuyama M; Thompson A; Tohyama H
    J Immunol; 1984 May; 132(5):2478-84. PubMed ID: 6201545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of three class II antigens, DR7, MB2, and MT3, from a homozygous human cell line.
    Shackelford DA; Strominger JL
    Hum Immunol; 1984 Mar; 9(3):159-74. PubMed ID: 6199337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
    Karr RW; Lipman LK; Alber C; Koning F; Goeken NE
    J Immunol; 1985 Oct; 135(4):2642-6. PubMed ID: 2411807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the separate molecular expression of four distinct polymorphic Ia epitopes on cells of DR4 homozygous individuals.
    Toguchi T; Burmester G; Nunez-Roldan A; Gregersen P; Seremetis S; Lee S; Szer I; Winchester R
    Hum Immunol; 1984 Jun; 10(2):69-81. PubMed ID: 6203881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong association of rheumatoid arthritis with the presence of a polymorphic Ia epitope defined by a monoclonal antibody: comparison with the allodeterminant DR4.
    Lee SH; Gregersen PK; Shen HH; Nunez-Roldan A; Silver J; Winchester RJ
    Rheumatol Int; 1984; 4 Suppl():17-23. PubMed ID: 6085817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cells homozygous for two HLA-DR7-associated HLA-D specificities express highly similar DR molecules but different DQ molecules.
    Karr RW; Hsu SH; Bias WB
    Hum Immunol; 1986 Feb; 15(2):198-210. PubMed ID: 3081469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Ia molecules carrying MT1 determinants: purification with a monoclonal antibody.
    Falk JA; Lewis WH; Letarte M
    Hum Immunol; 1985 Aug; 13(4):265-80. PubMed ID: 2411699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting.
    Radka SF; Machamer CE; Cresswell P
    Hum Immunol; 1984 Jul; 10(3):177-86. PubMed ID: 6611328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.